PMI 001 as stand-alone therapy in patients with rheumatoid arthritis: first of three US-based phase III trials
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 09 Nov 2010
At a glance
- Drugs Tripterygium wilfordii Hook F (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- 09 Nov 2010 Status changed from recruiting to active, no longer recruiting, based on a Phytomedics media release.
- 12 Sep 2009 New trial record.